Work

A single center experience of PIK3CA and AKT inhibitors in patients with hormone receptor positive metastatic breast cancer.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e13051

Authors: Yeonjoo Choi, Jiayi Tan, David Lin, Philomena McAndrew, Maryliza El-Masry, Dorothy J. Park, Natasha Banerjee, Cathie T. Chung, David M. J. Hoffman, Jin Sun Bitar, Yuan Yuan

Institution: Cedars-Sinai Medical Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410820290

FWCI:

Cites:

Cited by:

Related to: 10